A 32-year-old man with known HIV infection (CD4 count 85 cells/μL) presents with progressive dyspnea, fever, and a nonproductive cough for 2 weeks. Chest X-ray shows bilateral interstitial infiltrates. Which is the investigation of choice to confirm the suspected diagnosis?

## Diagnosis: Pneumocystis jirovecii Pneumonia (PCP) ### Clinical Presentation The patient has classic PCP features: - CD4 count <100 cells/μL (severe immunosuppression) - Subacute progressive dyspnea and nonproductive cough over 2 weeks - Bilateral interstitial infiltrates on chest X-ray ### Investigation of Choice: Induced Sputum with *P. jirovecii* PCR In current clinical practice, **induced sputum with PCR for *Pneumocystis jirovecii*** is the **investigation of choice** as the first-line diagnostic test for PCP. It is non-invasive, highly sensitive, and widely recommended by major guidelines (IDSA, BTS) before proceeding to invasive procedures. | Investigation | Sensitivity | Specificity | Role | |---|---|---|---| | **Induced sputum PCR** | 90–95% | ~95% | **First-line investigation of choice** | | **BAL with GMS stain** | 95–99% | ~99% | Gold standard / reserved for negative induced sputum | | **HRCT chest** | High | Low | Supportive, not confirmatory | | **Sputum AFB smear** | N/A for PCP | N/A | For TB, not PCP | ### Why Induced Sputum PCR? 1. **Non-invasive** — avoids the risks and discomfort of bronchoscopy 2. **High diagnostic yield** — sensitivity of 90–95% makes it reliable for initial confirmation 3. **Guideline-recommended first-line** — BAL is reserved for cases where induced sputum is negative or unavailable, not as the primary investigation 4. **Rapid turnaround** — PCR provides faster results compared to culture or staining techniques ### Why NOT BAL with GMS Staining (Option B)? While BAL with GMS staining remains the **gold standard** (highest sensitivity/specificity), it is an **invasive procedure** requiring bronchoscopy. Current guidelines recommend it only when induced sputum PCR is negative or cannot be performed, not as the initial investigation of choice. **Key Point:** The "investigation of choice" in modern PCP diagnosis is induced sputum PCR — non-invasive, highly sensitive, and first-line per IDSA/BTS guidelines. BAL is the gold standard fallback, not the first-line choice. **Clinical Pearl:** PCP prophylaxis with TMP-SMX is indicated when CD4 <200 cells/μL. In a patient already presenting with PCP (CD4 = 85), empirical treatment may be started while awaiting confirmation, but induced sputum PCR should be obtained first. **High-Yield:** Distinguish "investigation of choice" (first-line, least invasive with adequate sensitivity = induced sputum PCR) from "gold standard" (most accurate = BAL with GMS stain). Exam questions testing "investigation of choice" expect the former. [cite: Harrison's Principles of Internal Medicine, 21e, Ch. 197; IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults]